Who
Tobin W. Juvenal
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Castle Biosciences.
In numbers
- Trades disclosed
- 127
- Buys
- 0
- Sells
- 22
- Bought
- $0
- Sold
- $5.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 17 Jun 2021
- Last trade
- 12 Oct 2026
- Last filed
- 14 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Oct 2026filed 14 Oct 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $111K3,288 at $33.64 | filing |
| 30 Sep 2026filed 1 Oct 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $35K1,034 at $34.20 | filing |
| 29 Sep 2026filed 1 Oct 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $197K5,543 at $35.50 | filing |
| 15 Sep 2026filed 16 Sep 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $116K3,294 at $35.14 | filing |
| 15 Sep 2026filed 16 Sep 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $116K3,294 at $35.14 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $107K3,306 at $32.32 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $107K3,306 at $32.32 | filing |
| 31 Aug 2026filed 2 Sep 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $57K1,730 at $32.81 | filing |
| 31 Aug 2026filed 2 Sep 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $57K1,730 at $32.81 | filing |
| 25 Aug 2026filed 27 Aug 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $317K9,050 at $35.04 | filing |
| 25 Aug 2026filed 27 Aug 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $317K9,050 at $35.04 | filing |
| 17 Aug 2026filed 19 Aug 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $51K1,730 at $29.59 | filing |
| 17 Aug 2026filed 19 Aug 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $51K1,730 at $29.59 | filing |
| 3 Aug 2026filed 4 Aug 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $49K1,730 at $28.25 | filing |
| 3 Aug 2026filed 4 Aug 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $49K1,730 at $28.25 | filing |
| 31 Jul 2026filed 4 Aug 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $235K8,149 at $28.84 | filing |
| 31 Jul 2026filed 4 Aug 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $215K7,270 at $29.58 | filing |
| 31 Jul 2026filed 4 Aug 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $57K1,891 at $30.26 | filing |
| 31 Jul 2026filed 4 Aug 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $235K8,149 at $28.84 | filing |
| 31 Jul 2026filed 4 Aug 2026 | CSTL Castle BiosciencesDiagnostics & Labs | SEC FORM 4 Sold | $215K7,270 at $29.58 | filing |
News
Head to Head Analysis: Castle Biosciences (NASDAQ:CSTL) vs. Alignment Healthcare (NASDAQ:ALHC)CSTL · themarketsdaily.com · 15 Oct 2026Castle Biosciences (NASDAQ:CSTL) Insider Tobin Juvenal Sells 3,288 Shares of StockCSTL · themarketsdaily.com · 14 Oct 2026
0 headlines in the last 90 days name Tobin W. Juvenal; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.